|Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial|
EML Smith, H Pang, C Cirrincione, S Fleishman, ED Paskett, T Ahles, ...
Jama 309 (13), 1359-1367, 2013
|Pathway analysis using random forests classification and regression|
H Pang, A Lin, M Holford, BE Enerson, B Lu, MP Lawton, E Floyd, H Zhao
Bioinformatics 22 (16), 2028-2036, 2006
|Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease|
SK Murphy, H Yang, CA Moylan, H Pang, A Dellinger, MF Abdelmalek, ...
Gastroenterology 145 (5), 1076-1087, 2013
|The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease|
VL Gadd, R Skoien, EE Powell, KJ Fagan, C Winterford, L Horsfall, ...
Hepatology 59 (4), 1393-1405, 2014
|NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease|
WK Syn, KM Agboola, M Swiderska, GA Michelotti, E Liaskou, H Pang, ...
Gut 61 (9), 1323-1329, 2012
|Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease|
CA Moylan, H Pang, A Dellinger, A Suzuki, ME Garrett, CD Guy, ...
Hepatology 59 (2), 471-482, 2014
|Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis|
JD Yang, MF Abdelmalek, H Pang, CD Guy, AD Smith, AM Diehl, ...
Hepatology 59 (4), 1406-1414, 2014
|Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual …|
A Mauguen, JP Pignon, S Burdett, C Domerg, D Fisher, R Paulus, ...
The lancet oncology 14 (7), 619-626, 2013
|VATS lobectomy has better perioperative outcomes than open lobectomy: CALGB 31001, an ancillary analysis of CALGB 140202 (Alliance)|
CE Nwogu, J D’Cunha, H Pang, L Gu, X Wang, WG Richards, LJ Veit, ...
The Annals of thoracic surgery 99 (2), 399-405, 2015
|Chemotherapy with or without maintenance sunitinib for untreated extensive-stage small-cell lung cancer: a randomized, double-blind, placebo-controlled phase II study—CALGB …|
NE Ready, HH Pang, L Gu, GA Otterson, SP Thomas, AA Miller, ...
Journal of Clinical Oncology 33 (15), 1660, 2015
|A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307|
S Dubey, PA Jänne, L Krug, H Pang, X Wang, R Heinze, C Watt, ...
Journal of Thoracic Oncology 5 (10), 1655-1661, 2010
|Reporting and guidelines in propensity score analysis: a systematic review of cancer and cancer surgical studies|
XI Yao, X Wang, PJ Speicher, ES Hwang, P Cheng, DH Harpole, ...
JNCI: Journal of the National Cancer Institute 109 (8), djw323, 2017
|Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study|
NE Ready, AZ Dudek, HH Pang, LD Hodgson, SL Graziano, MR Green, ...
Journal of clinical oncology 29 (33), 4436, 2011
|Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance)|
AB Nixon, H Pang, MD Starr, PN Friedman, MM Bertagnolli, HL Kindler, ...
Clinical Cancer Research 19 (24), 6957-6966, 2013
|Shrinkage‐based diagonal discriminant analysis and its applications in high‐dimensional data|
H Pang, T Tong, H Zhao
Biometrics 65 (4), 1021-1029, 2009
|Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab|
Y Liu, MD Starr, A Bulusu, H Pang, NS Wong, W Honeycutt, A Amara, ...
Cancer medicine 2 (2), 234-242, 2013
|Alliance for Clinical Trials in Oncology. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a …|
EM Smith, H Pang, C Cirrincione, S Fleishman, ED Paskett, T Ahles, ...
Jama 309 (13), 1359-1367, 2013
|A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer|
I Altomare, JC Bendell, KE Bullock, HE Uronis, MA Morse, SD Hsu, ...
The oncologist 16 (8), 1131, 2011
|Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304)|
GA Otterson, L Hodgson, H Pang, EE Vokes, ...
Journal of Thoracic Oncology 5 (10), 1644-1648, 2010
|Gene selection using iterative feature elimination random forests for survival outcomes|
H Pang, SL George, K Hui, T Tong
IEEE/ACM transactions on computational biology and bioinformatics 9 (5 …, 2012